GB9810464D0 - Hydroxamic acid derivatives - Google Patents

Hydroxamic acid derivatives

Info

Publication number
GB9810464D0
GB9810464D0 GBGB9810464.9A GB9810464A GB9810464D0 GB 9810464 D0 GB9810464 D0 GB 9810464D0 GB 9810464 A GB9810464 A GB 9810464A GB 9810464 D0 GB9810464 D0 GB 9810464D0
Authority
GB
United Kingdom
Prior art keywords
group
alkyl
independently
alk
acid derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9810464.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis R&D Ltd
Original Assignee
British Biotech Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharmaceuticals Ltd filed Critical British Biotech Pharmaceuticals Ltd
Priority to GBGB9810464.9A priority Critical patent/GB9810464D0/en
Publication of GB9810464D0 publication Critical patent/GB9810464D0/en
Priority to KR1020007012819A priority patent/KR100634089B1/ko
Priority to JP2000549233A priority patent/JP2002515427A/ja
Priority to AU39421/99A priority patent/AU754063B2/en
Priority to PT99922317T priority patent/PT1079819E/pt
Priority to DE69934309T priority patent/DE69934309T2/de
Priority to TR2000/03376T priority patent/TR200003376T2/xx
Priority to ES99922317T priority patent/ES2278444T3/es
Priority to CN99806057A priority patent/CN1300210A/zh
Priority to BR9910488-1A priority patent/BR9910488A/pt
Priority to PL99344438A priority patent/PL344438A1/xx
Priority to EP06009622A priority patent/EP1754477A3/en
Priority to GB0024789A priority patent/GB2353708A/en
Priority to HU0102290A priority patent/HUP0102290A3/hu
Priority to IL13905999A priority patent/IL139059A0/xx
Priority to EP99922317A priority patent/EP1079819B1/en
Priority to CA002332713A priority patent/CA2332713C/en
Priority to NZ507560A priority patent/NZ507560A/xx
Priority to PCT/GB1999/001541 priority patent/WO1999059568A1/en
Priority to US09/700,424 priority patent/US6441042B1/en
Priority to DK99922317T priority patent/DK1079819T3/da
Priority to AT99922317T priority patent/ATE347356T1/de
Priority to IL139059A priority patent/IL139059A/en
Priority to ZA200006131A priority patent/ZA200006131B/en
Priority to NO20005782A priority patent/NO20005782L/no
Priority to US10/179,227 priority patent/US6992190B2/en
Priority to US11/207,813 priority patent/US7323563B2/en
Priority to CY20071100285T priority patent/CY1106452T1/el
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
GBGB9810464.9A 1998-05-16 1998-05-16 Hydroxamic acid derivatives Ceased GB9810464D0 (en)

Priority Applications (28)

Application Number Priority Date Filing Date Title
GBGB9810464.9A GB9810464D0 (en) 1998-05-16 1998-05-16 Hydroxamic acid derivatives
AT99922317T ATE347356T1 (de) 1998-05-16 1999-05-14 Hydroxamsäurederivate als antibakterielle arzneimittel
GB0024789A GB2353708A (en) 1998-05-16 1999-05-14 Hydroxamic acid derivatives as antibacterials
IL13905999A IL139059A0 (en) 1998-05-16 1999-05-14 Hydroxamic acid derivates as antibacterials
AU39421/99A AU754063B2 (en) 1998-05-16 1999-05-14 Hydroxamic acid derivatives as antibacterials
PT99922317T PT1079819E (pt) 1998-05-16 1999-05-14 Derivados de ácido hidroxâmico como antibacterianos
DE69934309T DE69934309T2 (de) 1998-05-16 1999-05-14 Hydroxamsäurederivate als antibakterielle arzneimittel
TR2000/03376T TR200003376T2 (tr) 1998-05-16 1999-05-14 Antibakteriyeller olarak hidroksamik asit türevleri
ES99922317T ES2278444T3 (es) 1998-05-16 1999-05-14 Derivados del acido hidroxamico como antibacterianos.
CN99806057A CN1300210A (zh) 1998-05-16 1999-05-14 作为抗菌剂的异羟肟酸衍生物
BR9910488-1A BR9910488A (pt) 1998-05-16 1999-05-14 Derivados do ácido hidroxâmico como antibacterianos
PL99344438A PL344438A1 (en) 1998-05-16 1999-05-14 Hydroxamic acid derivatives as antibacterials
EP06009622A EP1754477A3 (en) 1998-05-16 1999-05-14 Hydroxamic acid derivatives as antibacterials
KR1020007012819A KR100634089B1 (ko) 1998-05-16 1999-05-14 항박테리아제로서의 히드록삼산 유도체
HU0102290A HUP0102290A3 (en) 1998-05-16 1999-05-14 Use of hydroxamic acid derivatives for producing pharmaceutical compositions having antibacterial activity
JP2000549233A JP2002515427A (ja) 1998-05-16 1999-05-14 抗菌剤としてのヒドロキサム酸誘導体
EP99922317A EP1079819B1 (en) 1998-05-16 1999-05-14 Hydroxamic acid derivatives as antibacterials
CA002332713A CA2332713C (en) 1998-05-16 1999-05-14 Hydroxamic acid derivatives as antibacterials
NZ507560A NZ507560A (en) 1998-05-16 1999-05-14 Hydroxamic acid derivatives as antibacterials
PCT/GB1999/001541 WO1999059568A1 (en) 1998-05-16 1999-05-14 Hydroxamic acid derivatives as antibacterials
US09/700,424 US6441042B1 (en) 1998-05-16 1999-05-14 Hydroxamic acid derivatives as antibacterials
DK99922317T DK1079819T3 (da) 1998-05-16 1999-05-14 Hydroxamsyrederivater som antibakterielle lægemidler
IL139059A IL139059A (en) 1998-05-16 2000-10-16 Use of a history of hydroxamic acid for the preparation of antibacterial drugs
ZA200006131A ZA200006131B (en) 1998-05-16 2000-10-30 Hydroxamic acid derivatives as antibacterials.
NO20005782A NO20005782L (no) 1998-05-16 2000-11-15 Hydroksaminsyrederivater som antibakterielle midler
US10/179,227 US6992190B2 (en) 1998-05-16 2002-06-26 Hydroxamic acid derivatives as antibacterials
US11/207,813 US7323563B2 (en) 1998-05-16 2005-08-22 Hydroxamic acid derivatives as antibacterials
CY20071100285T CY1106452T1 (el) 1998-05-16 2007-03-01 Παραγωγα του υδροξαμικου οξεως ως αντιβακτηριακα

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9810464.9A GB9810464D0 (en) 1998-05-16 1998-05-16 Hydroxamic acid derivatives

Publications (1)

Publication Number Publication Date
GB9810464D0 true GB9810464D0 (en) 1998-07-15

Family

ID=10832125

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9810464.9A Ceased GB9810464D0 (en) 1998-05-16 1998-05-16 Hydroxamic acid derivatives
GB0024789A Withdrawn GB2353708A (en) 1998-05-16 1999-05-14 Hydroxamic acid derivatives as antibacterials

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0024789A Withdrawn GB2353708A (en) 1998-05-16 1999-05-14 Hydroxamic acid derivatives as antibacterials

Country Status (23)

Country Link
US (3) US6441042B1 (enExample)
EP (2) EP1079819B1 (enExample)
JP (1) JP2002515427A (enExample)
KR (1) KR100634089B1 (enExample)
CN (1) CN1300210A (enExample)
AT (1) ATE347356T1 (enExample)
AU (1) AU754063B2 (enExample)
BR (1) BR9910488A (enExample)
CA (1) CA2332713C (enExample)
CY (1) CY1106452T1 (enExample)
DE (1) DE69934309T2 (enExample)
DK (1) DK1079819T3 (enExample)
ES (1) ES2278444T3 (enExample)
GB (2) GB9810464D0 (enExample)
HU (1) HUP0102290A3 (enExample)
IL (2) IL139059A0 (enExample)
NO (1) NO20005782L (enExample)
NZ (1) NZ507560A (enExample)
PL (1) PL344438A1 (enExample)
PT (1) PT1079819E (enExample)
TR (1) TR200003376T2 (enExample)
WO (1) WO1999059568A1 (enExample)
ZA (1) ZA200006131B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL194240B1 (pl) * 1998-02-07 2007-05-31 British Biotech Pharm Zastosowanie pochodnych N-formylohydroksyloaminy i amidowa pochodna N-formylohydroksyloaminy
GB9810464D0 (en) * 1998-05-16 1998-07-15 British Biotech Pharm Hydroxamic acid derivatives
ES2242411T3 (es) * 1999-08-10 2005-11-01 Vernalis (Oxford) Ltd Agentes antibacterianos.
FR2801591B1 (fr) * 1999-11-30 2002-03-01 Aventis Pharma Sa Derives macrocycliques de l'acide hydroxamique, leur preparation et les compositions qui les contiennent
AU2180201A (en) * 1999-11-30 2001-06-12 Aventis Pharma S.A. Hydroxamic acid macrocyclic derivatives, preparation method and compositions containing same
EP1237862A1 (en) * 1999-12-17 2002-09-11 Versicor, Inc. Succinate compounds, compositions and methods of use and preparation
GB9929979D0 (en) * 1999-12-17 2000-02-09 Darwin Discovery Ltd Hydroxamic acid derivatives
WO2002028829A2 (en) * 2000-09-25 2002-04-11 Questcor Pharmaceuticals, Inc. Peptide deformylase inhibitors
AU2002212541A1 (en) * 2000-11-23 2002-06-03 British Biotech Pharmaceuticals Ltd Ydroxamic acid or n-formyl hydroxylamine derivatives as inhibitors of bakterial polypeptide deformylase for treating microbial infections
JP2004532826A (ja) * 2001-03-19 2004-10-28 スローン−ケッタリング インスティトゥート フォー カンサー リサーチ （ｓ，ｒ，ｒ）−（−）−アクチノニンおよびそのアナログの不斉合成、ならびにそれらの使用
US20040267015A1 (en) * 2001-04-05 2004-12-30 Ajita Bhat Peptide deformylase inhibitors
GB0128943D0 (en) 2001-12-04 2002-01-23 Novo Pharmaceuticals De Ltd Bacterial enzyme inhibitors
JP4190862B2 (ja) * 2001-12-18 2008-12-03 シャープ株式会社 表示装置およびその駆動方法
GB0208579D0 (en) * 2002-04-13 2002-05-22 British Biotech Pharm Antibacterial agents
DE10320453A1 (de) * 2003-05-08 2004-11-25 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Bioisostere von Actinonin
ES2582555T3 (es) * 2007-11-29 2016-09-13 Inolex Investment Corporation Conservantes para composiciones cosméticas, de tocador y farmacéuticas
DE102011088962A1 (de) * 2011-12-19 2013-06-20 Beiersdorf Ag Wirkstoffkombinationen aus einer oder mehreren Carbonsäuren, insbesondereHydroxycarbonsäuren, und einer oder mehreren physiologisch unbedenklichen Hydroxamsäure sowie kosmetische oder dermatologische Zubereitungen, solcheWirkstoffkombinationen enthaltend
US10829440B2 (en) 2015-06-12 2020-11-10 Brown University Antibacterial compounds and methods of making and using same
CN111787800B (zh) * 2017-06-29 2022-11-25 金伯利-克拉克环球有限公司 包含二异羟肟酸的抗微生物组合物及用其抑制微生物生长的方法
CN108672095A (zh) * 2018-05-04 2018-10-19 广东省资源综合利用研究所 γ-羟基烷基羟肟酸及其制备方法与应用
US11555010B2 (en) 2019-07-25 2023-01-17 Brown University Diamide antimicrobial agents

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1028921A (en) 1962-01-23 1966-05-11 Ranjeet Bhagwan Singh New antibiotic
US4303662A (en) * 1980-11-24 1981-12-01 E. R. Squibb & Sons, Inc. Carboxyacyl, mercapto and acylmercapto derivatives of heterobicyclo compounds
JPH0670019B2 (ja) 1989-07-21 1994-09-07 明治製菓株式会社 新抗生物質ｓｆ２１９７ｃ物質およびその製造法
GB8919251D0 (en) * 1989-08-24 1989-10-04 British Bio Technology Compounds
JPH03157372A (ja) 1989-11-13 1991-07-05 Yamanouchi Pharmaceut Co Ltd Ｙｌ―０１８６９ｐ物質及びその製造法
WO1992022523A2 (en) 1991-06-14 1992-12-23 Research Corporation Technologies, Inc. Peptide derivatives of collagenase inhibitor
GB9223904D0 (en) * 1992-11-13 1993-01-06 British Bio Technology Inhibition of cytokine production
FI960803L (fi) * 1993-08-23 1996-04-22 Immunex Corp TNF-alfa-sekreetion inhibiittoreita
JP3157372B2 (ja) 1993-11-29 2001-04-16 三洋電機株式会社 フィルタ
AU690703B2 (en) * 1994-06-22 1998-04-30 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors
US5532265A (en) 1994-11-30 1996-07-02 The Board Of Trustees Of The Leland Stanford Junior University Treatment of central nervous system inflammatory disease with matrix metalloprotease inhibitors
GB9507799D0 (en) * 1995-04-18 1995-05-31 British Biotech Pharm Metalloproteinase inhibitors
US6281245B1 (en) * 1996-10-28 2001-08-28 Versicor, Inc. Methods for solid-phase synthesis of hydroxylamine compounds and derivatives, and combinatorial libraries thereof
AU5187698A (en) 1996-12-06 1998-06-29 Cancerforskningsfondet Af 1989 Inhibition of invasive remodelling
ZA9711121B (en) * 1996-12-13 1998-06-23 Handelman Joseph H Reduction of hair growth.
PL194240B1 (pl) * 1998-02-07 2007-05-31 British Biotech Pharm Zastosowanie pochodnych N-formylohydroksyloaminy i amidowa pochodna N-formylohydroksyloaminy
GB9810464D0 (en) * 1998-05-16 1998-07-15 British Biotech Pharm Hydroxamic acid derivatives

Also Published As

Publication number Publication date
CA2332713C (en) 2008-04-01
TR200003376T2 (tr) 2001-03-21
HUP0102290A2 (hu) 2001-11-28
DK1079819T3 (da) 2007-04-10
KR100634089B1 (ko) 2006-10-17
US20060211732A1 (en) 2006-09-21
EP1079819A1 (en) 2001-03-07
CN1300210A (zh) 2001-06-20
US6992190B2 (en) 2006-01-31
US7323563B2 (en) 2008-01-29
EP1079819B1 (en) 2006-12-06
ATE347356T1 (de) 2006-12-15
CA2332713A1 (en) 1999-11-25
ES2278444T3 (es) 2007-08-01
US20020198241A1 (en) 2002-12-26
EP1754477A2 (en) 2007-02-21
NO20005782D0 (no) 2000-11-15
IL139059A (en) 2006-12-31
KR20010034861A (ko) 2001-04-25
PT1079819E (pt) 2007-03-30
CY1106452T1 (el) 2011-10-12
NZ507560A (en) 2003-06-30
EP1754477A3 (en) 2007-03-14
AU3942199A (en) 1999-12-06
IL139059A0 (en) 2001-11-25
GB0024789D0 (en) 2000-11-22
JP2002515427A (ja) 2002-05-28
GB2353708A (en) 2001-03-07
ZA200006131B (en) 2002-01-30
PL344438A1 (en) 2001-11-05
US6441042B1 (en) 2002-08-27
AU754063B2 (en) 2002-10-31
DE69934309T2 (de) 2007-07-05
WO1999059568A1 (en) 1999-11-25
BR9910488A (pt) 2001-01-09
DE69934309D1 (de) 2007-01-18
NO20005782L (no) 2001-01-15
HUP0102290A3 (en) 2001-12-28

Similar Documents

Publication Publication Date Title
GB0024789D0 (en) Hydroxamic acid derivatives as antibacterials
GB2349884A (en) Antibacterial agents
DK0804421T3 (da) 2-((Dihydro)pyrazolyl-3'-oxymethylen)-anilider som skadedyrsbekæmpelsesmidler og fungicider
BR9809531A (pt) Composições herbicidas.
AU2001276416A1 (en) Substituted triazolopyrid(az)ines as plant treatment agents (herbicides)
GR3018848T3 (en) Erythromycin derivatives, their preparation, intermediates obtained and their application as medicaments
ES2110673T3 (es) N-azinil-n'-(het)arilsulfonil-ureas como herbicidas.
ATE399545T1 (de) Mittel zur verringerung der eigeweidefette
PT870761E (pt) Derivados de tiocolchicina com actividades anti-inflamatoria e relaxante muscular
IE802135L (en) Pyrazolobenzodiazepines
WO1995001170A3 (en) Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders
BR0014702A (pt) Composição de glifosato herbicida, e, método de formação de uma composição de glifosato para a aplicação a ervas daninhas
EP1000923A4 (en) CYCLOPENTEN DERIVATIVES
PT1194039E (pt) Composicao de pesticida e metodo para controlar pragas
AU5879798A (en) Agents inhibiting progress of pterygium and postoperative recurrence of the same
AP9701140A0 (en) New hydroximic acid derivatives.
ES2059918T3 (es) Metazacloro monoclinico y procedimiento para su fabricacion.
DE69912639D1 (de) N-formyl hydroxylamin derivate als antibakterielle mittel
EA199900888A1 (ru) Противоревматические средства
BR9909029A (pt) Estabilização de poliisocianatos orgânicos
ATE252573T1 (de) 2-aryloxy-4-methyl-6-pyrazol-1-yl-pyridine wirksam als herbizide
ATE204294T1 (de) Thiol derivate mit metallopeptidase inhibierender aktivitat
AU1978700A (en) Coloring agents comprising manganese cations
CA2278553A1 (en) Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulators
EP1486489A3 (en) Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)